Navigation Links
Synthetic Biologics Responds to Recent CDC Report on Threat of "Super Bugs"
Date:9/20/2013

ns mobile device app, which allows users access to the Company's SEC documents, press releases and events, please click on the following links to download the IRapp on your iPhone and iPad or your Android mobile device.

This release includes forward-looking statements on Synthetic Biologics' current expectations and projections about future events. In some cases forward-looking statements can be identified by terminology such as "may," "should," "potential," "continue," "expects," "anticipates," "intends," "plans," "believes," "estimates," and similar expressions. These statements are based upon current beliefs, expectations and assumptions and are subject to a number of risks and uncertainties, many of which are difficult to predict and include statements regarding the intent of the CDC's statements. The forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those set forth or implied by any forward-looking statements. Important factors that could cause actual results to differ materially from those reflected in Synthetic Biologics' forward-looking statements include, among others, a failure of SYN-004 to be demonstrably safe and effective or successfully commercialized, the development of competitive products, a failure to initiate animal trials or clinical trials and if initiated a failure to initiate them when planned or achieve the desired results, a failure to obtain regulatory approval for SYN-004 or to comply with ongoing regulatory requirements and other factors described in Synthetic Biologics' report on Form 10-K for the year ended December 31, 2012 and any other filings with the SEC. The information in this release is provided only as of the date of this release, and Synthetic Biologics undertakes no obl
'/>"/>

SOURCE Synthetic Biologics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Synthetic Biologics to Present at the 15th Annual Rodman & Renshaw Global Investment Conference in New York City
2. Synthetic Biologics Reports Second Quarter 2013 Financial Results and Operational Update
3. Synthetic Biologics to Report Second Quarter 2013 Financial Results
4. Synthetic Biologics Initiates Manufacturing Process for C. difficile Infectious Disease Program
5. Synthetic DNA Deemed Patentable by US Supreme Court, Gene Synthesis and Codon Optimization Provide Potential Pathway to Patentability
6. Synthetic Biologics to Present at OneMedForum New York 2013
7. New England Biolabs supports iGEM synthetic biology competition
8. Synthetic Biologics to Present at the 2nd Annual Marcum LLP MicroCap Conference
9. Intrexon Organizes Around New Synthetic Biology Markets
10. Intrexon Corporation Raises $150 Million for Synthetic Biology Initiatives
11. Synthetic Biologics Reiterates that the Infectious Disease Collaboration with Intrexon Remains in Effect
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... British Columbia , March 2, 2015 /PRNewswire/ ... a clinical stage biopharmaceutical company specializing in the ... Craig Schneider , Chief Executive Officer, will ... at VirtualInvestorConferences.com. DATE: Thursday, March 5, ... click the red "register/ watch event now" button ...
(Date:3/2/2015)... , March 2, 2015 ... to bottom.   Moments ago, Analysts Review ... Sunshine Heart (NASDAQ: SSH ), Synergetics ... Syneron Medical (NASDAQ: ELOS ), Spectranetics (NASDAQ: ... Analysts Review provides a single unified platform for investors, to ...
(Date:3/2/2015)... Kent, WA (PRWEB) March 02, 2015 ... tangential flow flat-sheet testing system at the 2015 AMTA ... is a culmination of a decade’s worth of engineering ... system compatible with a wide range of applications across ... be versatile enough to meet the dynamic needs of ...
(Date:3/1/2015)... Market Publishers Ltd and DataGroup Booksellers ... promotion on Internet. MarketPublishers.com is now authorised to ... DataGroup Booksellers. , Natalie Aster, Assistant Manager at ... the recent partnership agreement as follows: “We are ... of publishers. Since 1974, the company has been ...
Breaking Biology Technology:InMed Pharmaceuticals to Present Investor Webcast March 5 2Quarterly Report Card of Biotechnology Companies: New Research on Sunshine Heart, Synergetics USA, Syneron Medical, Spectranetics and Thoratec 2Quarterly Report Card of Biotechnology Companies: New Research on Sunshine Heart, Synergetics USA, Syneron Medical, Spectranetics and Thoratec 3Quarterly Report Card of Biotechnology Companies: New Research on Sunshine Heart, Synergetics USA, Syneron Medical, Spectranetics and Thoratec 4Sterlitech Displays Complete CF042 Membrane Test System 2Market Publishers Ltd and DataGroup Booksellers Sign Partnership Agreement 2Market Publishers Ltd and DataGroup Booksellers Sign Partnership Agreement 3
... Rochelle, NY, February 8, 2011Successful intranasal delivery of ... Parkinson disease yielded significant improvement in motor function ... disease. These highly promising findings, reported in ... Mary Ann Liebert, Inc. highlight the potential for ...
... ST. LOUIS, Feb. 16, 2011 / PRNewswire/ ... announces the following executive leadership appointments intended to ... strategic plan. Frank Wicks, President Research, ... Research products, including those in Research Essentials, Research ...
... 16, 2011 Pneumococcus ( Streptococcus pneumoniae ) ... mortality in young children worldwide. While successful vaccines ... work against specific pneumococcal strains, with the risk ... Through a novel discovery approach, researchers at Children,s ...
Cached Biology Technology:Sigma-Aldrich Announces Organizational Changes 2Sigma-Aldrich Announces Organizational Changes 3New Pneumococcal Vaccine Approach Successful in Early Tests 2New Pneumococcal Vaccine Approach Successful in Early Tests 3New Pneumococcal Vaccine Approach Successful in Early Tests 4
(Date:1/22/2015)... 2015 /PRNewswire/ - Today, FindBiometrics, the leading source of biometrics industry ... new website design. "When we launched FindBiometrics 12 ... Peter O,Neill , founder and CEO of FindBiometrics. "Now it,s ... from the key players on a very broad scale.  We ...
(Date:1/22/2015)... Wis. , Jan. 15, 2015  BellBrook Labs, ... drug discovery, announced the launch of a TR-FRET ... the company,s Transcreener UDP Assay, a high throughput ... The new assay will allow for sensitive detection ...
(Date:1/22/2015)... POINT ROBERTS, Washington , January 20, 2015 ... technology and tech stocks, releases video from the CES 2015 ... security consultant Apollo Robbins . Apollo shows ... Wocket™ biometric smart wallet, a product of NXT-ID, Inc. (NASDAQ: ...
Breaking Biology News(10 mins):Identity Industry Leading Publication Debuts New Look As Biometrics Hit Mainstream 2BellBrook Labs Launches a High Throughput Screening Assay for Glycosyltransferases with TR-FRET Readout 2Apollo Robbins Talks about the Illusion of Personal Safety and How Easily Your Wallet is Stolen; If a Wocket Wallet is Stolen the Thief Can't do Anything With it! 2Apollo Robbins Talks about the Illusion of Personal Safety and How Easily Your Wallet is Stolen; If a Wocket Wallet is Stolen the Thief Can't do Anything With it! 3
... Relatives of a young person who dies suddenly should ... order to identify if they too are at risk ... of the European Society of Human Genetics today (Tuesday ... a research fellow at the Department of Cardiogenetics, Academic ...
... some of our immune proteins into the inflammatory defenders they ... appear in the June 8 issue of the Journal ... by a team of researchers in Italy, also suggests that ... into risk factors for intestinal disorders. Parasite-driven selection ...
... TEMPE, Ariz. The International Institute for Species Exploration ... taxonomists scientists responsible for species exploration and classification ... in 2008. On the list are a pea-sized ... The top 10 new species also include the very ...
Cached Biology News:Comprehensive cardiogenetic testing for families of sudden unexplained death victims can save lives 2Immune genes adapt to parasites 2Scientists announce top 10 new species; issue SOS 2Scientists announce top 10 new species; issue SOS 3Scientists announce top 10 new species; issue SOS 4Scientists announce top 10 new species; issue SOS 5
Peptide-affinity Purified Polyclonal Antibody to Prolactin Releasing Hormone Receptor (GPR10)...
... BalanceTalk XL provides balance data collection and ... Complete integration with Microsoft Excel , ... moisture analyzers , New balances can be added ... Collect data from multiple balances into one spreadsheet ...
Applications: Western blotting ...
...
Biology Products: